Fig. 4From: A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicalsDetermining the strength of the evidence for the endocrine disrupting activity of a chemical. Evidence is characterized as “strong”, “moderate”, “weak,” or “no data”. If observational or in silico data is considered strong, upgrade “weak” to “moderate”, or “moderate” to “strong”Back to article page